InsiderTrades

Form 4 for ROIV Roivant Sciences Ltd.

Accepted 2023-10-18 00:00:00 ET · period of report 2023-10-16 · accession 0001140361-23-048777 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
T 2023-10-18 2022-10-16 ROIV MOMTAZEE JAMES C Dir A - Grant $0.00 +1,594 75.5K +2% $0
T 2023-10-18 2023-10-17 ROIV MOMTAZEE JAMES C Dir J - Other $10.30 -687 74.8K -0.9% -$7,076

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2022-10-16 A A 1,594 $0.00 75,456 D — — (F1) Reflects an award of restricted stock covering Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. (F2) The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and the filing of this statement shall not be deemed an admission that the reporting person is, for purposes of Section 16 or otherwise, the beneficial owner of any of the reported securities.
2 Common Common Shares 2023-10-17 J D 687 $10.30 74,769 D — — (F3) Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering Common Shares. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person. (F2) The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and the filing of this statement shall not be deemed an admission that the reporting person is, for purposes of Section 16 or otherwise, the beneficial owner of any of the reported securities.